相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hesperidin potentially interacts with the catalytic site of gamma-secretase and modifies notch sensitive genes and cancer stemness marker expression in colon cancer cells and colonosphere
Atul Kumar Singh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4
Dan Xie et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
Promoting Apoptosis, a Promising Way to Treat Breast Cancer With Natural Products: A Comprehensive Review
Lie Yuan et al.
FRONTIERS IN PHARMACOLOGY (2022)
MiR-181c sensitizes ovarian cancer cells to paclitaxel by targeting GRP78 through the PI3K/Akt pathway
Li-ying Zhang et al.
CANCER GENE THERAPY (2022)
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
Ridho Assidicky et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres
Kumari Sunita Prajapati et al.
MOLECULAR CARCINOGENESIS (2022)
Rutin Potentially Binds the Gamma Secretase Catalytic Site, Down Regulates the Notch Signaling Pathway and Reduces Sphere Formation in Colonospheres
Atul Kumar Singh et al.
METABOLITES (2022)
Implications of Withaferin-A for triple-negative breast cancer chemoprevention
Harshini Mallipeddi et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Five-Decade Update on Chemopreventive and Other Pharmacological Potential of Kurarinone: a Natural Flavanone
Shashank Kumar et al.
FRONTIERS IN PHARMACOLOGY (2021)
Pulveraven A from the fruiting bodies of Pulveroboletus ravenelii induces apoptosis in breast cancer cell via extrinsic apoptotic signaling pathway
Dahae Lee et al.
JOURNAL OF ANTIBIOTICS (2021)
Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
Radhakrishnan Vishnubalaji et al.
SCIENTIFIC REPORTS (2021)
Identification of cancer stemness related miRNA(s) using integrated bioinformatics analysis and in vitro validation
Kumari Sunita Prajapati et al.
3 BIOTECH (2021)
RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells
Su-Hyeong Kim et al.
CARCINOGENESIS (2020)
The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
Alessia Indrieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP)
Niuniu Li et al.
ONCOTARGETS AND THERAPY (2020)
A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer
Eun-Ryeong Hahm et al.
CANCER PREVENTION RESEARCH (2020)
Natural Agents Targeting Mitochondria in Cancer
Shalini Mani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway
Jikui Sun et al.
CELL DEATH & DISEASE (2020)
Induction of apoptosis in breast cancer cells by naphthylisoquinoline alkaloids
Prem Prakash Kushwaha et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells
Hui-Chun Wang et al.
PHYTOMEDICINE (2019)
The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a
Rana A. Youness et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
Jiyuan Ai et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells
Prem Prakash Kushwaha et al.
LIFE SCIENCES (2019)
MiR-181c affects estrogen-dependent endometria carcinoma cell growth by targeting PTEN
Lili Zhuang et al.
ENDOCRINE JOURNAL (2019)
MCL-1 is a prognostic indicator and drug target in breast cancer
Kirsteen J. Campbell et al.
CELL DEATH & DISEASE (2018)
Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients
Petar Ozretic et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
Katarzyna Szarc Vel Szic et al.
ONCOTARGET (2017)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells
Katarzyna Szarc vel Szic et al.
PLOS ONE (2014)
miR-181c Regulates the Mitochondrial Genome, Bioenergetics, and Propensity for Heart Failure In Vivo
Samarjit Das et al.
PLOS ONE (2014)
In Vitro Antioxidant, Antibacterial, and Cytotoxic Activity and In Vivo Effect of Syngonium podophyllum and Eichhornia crassipes Leaf Extracts on Isoniazid Induced Oxidative Stress and Hepatic Markers
Shashank Kumar et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Gambogenic Acid Induction of Apoptosis in a Breast Cancer Cell Line
Jing Zhou et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Chemistry and Biological Activities of Flavonoids: An Overview
Shashank Kumar et al.
SCIENTIFIC WORLD JOURNAL (2013)
Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species
Eun-Ryeong Hahm et al.
PLOS ONE (2011)
Antiproliferative Activity of Withanolides against Human Breast Cancer Cell Lines
Ruben P. Machin et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine
Mohammad Hossein Mirjalili et al.
MOLECULES (2009)
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
SA Lakhani et al.
SCIENCE (2006)
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide
AP Simoes-Wüst et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)